Clinical Study
Comparative Genomic Hybridization Selection of Blastocysts for Repeated Implantation Failure Treatment: A Pilot Study
Table 2
Oocytes, embryos, and blastocysts obtained in the three groups.
| | | Group RIF PGS
() | Group RIF NO PGS
() | Group NO RIF PGS
() | |
| | Number of oocytes | 645 | 519 | 681 | | | Metaphase II | 530 (82.2%) | 454 (87.5%) | 556 (81.6%) | 0.014
A versus B 0.026*
A versus C 1.00* | | Fertilized oocytes | 433 (81.7%) | 373 (82.2%) | 451 (81.1%) | 0.912 | | Embryos | 392 (90.5%) | 337 (90.3%) | 408 (90.5%) | 0.996 | | Day 3 grade A | 236 (60.2%) | 210 (62.3%) | 246 (60.3%) | 0.013 | | Day 3 grade B | 105 (26.8%) | 64 (19.0%) | 112 (27.5%) | A versus B 0.026* | | Day 3 grade C | 51 (13.0%) | 63 (18.7%) | 50 (12.3%) | A versus C 1.00* | | Blastocysts | 190 (48.5%) | 171 (50.7%) | 257 (63.0%) | <0.001
A versus B 1.00*
A versus C 0.001* | | Day 5 | 83 (43.7%) | 87 (50.9%) | 108 (42.0%) | <0.001 | | Day 6 | 96 (50.5%) | 51 (29.8%) | 125 (48.6%) | A versus B 0.001* | | Day 7 | 11 (5.8%) | 33 (19.3%) | 24 (9.3%) | A versus C 0.770* |
|
|
After Bonferroni’s correction.
|
